Literature DB >> 14764672

Mechanisms governing B cell developmental defects in invariant chain-deficient mice.

Kamel Benlagha1, Se-Ho Park, Rodolphe Guinamard, Claire Forestier, Lars Karlsson, Cheong-Hee Chang, Albert Bendelac.   

Abstract

Invariant chain (Ii)-deficient mice exhibit profound B cell defects that have remained poorly understood, because they could not be simply explained by impaired Ag presentation. We found that Ii deficiency induced cell autonomous defects of two distinct B cell lineages. The life span of mature follicular (FO) B cells was reduced, accounting for their markedly decreased frequency, whereas, in contrast, marginal zone (MZ) B cells accumulated. Other Ii-expressing lineages such as B1 B cells and dendritic cells were unaffected. Surprisingly, the life span of FO B cells was fully corrected in Ii/I-Abeta doubly deficient mice, revealing that Ii-free I-Abeta chains alter FO B cell survival. In contrast, the accumulation of MZ B cells was controlled by a separate mechanism independent of I-Abeta. Interestingly, in Ii-deficient mice lacking FO B cells, the MZ B cells invaded the FO zone, suggesting that intact follicules contribute to the retention of B cells in the MZ. These findings reveal unexpected consequences of Ii deficiency on the development and organization of B cell follicles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764672     DOI: 10.4049/jimmunol.172.4.2076

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Surveillance B lymphocytes and mucosal immunoregulation.

Authors:  Peter Velázquez; Bo Wei; Jonathan Braun
Journal:  Springer Semin Immunopathol       Date:  2004-12-18

2.  The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface.

Authors:  Lynne S Arneson; Jim Miller
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

3.  mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity.

Authors:  Naresh Kumar Meena; Shakti Prasad Pattanayak; Yael Ben-Nun; Sandrine Benhamron; Saran Kumar; Emmanuelle Merquiol; Nadine Hövelmeyer; Galia Blum; Boaz Tirosh
Journal:  Immunology       Date:  2018-09-16       Impact factor: 7.397

4.  CD74 is a member of the regulated intramembrane proteolysis-processed protein family.

Authors:  Shirly Becker-Herman; Galit Arie; Helena Medvedovsky; Anat Kerem; Idit Shachar
Journal:  Mol Biol Cell       Date:  2005-08-17       Impact factor: 4.138

5.  A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.

Authors:  Magdalena Pyrz; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

6.  Restricted MHC-peptide repertoire predisposes to autoimmunity.

Authors:  Nadezda N Logunova; Christophe Viret; Leonid A Pobezinsky; Sara A Miller; Dmitri B Kazansky; John P Sundberg; Alexander V Chervonsky
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

7.  B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A.

Authors:  Hannes Bergmann; Mehmet Yabas; Alanna Short; Lisa Miosge; Nadine Barthel; Charis E Teh; Carla M Roots; Katherine R Bull; Yogesh Jeelall; Keisuke Horikawa; Belinda Whittle; Bhavani Balakishnan; Geoff Sjollema; Edward M Bertram; Fabienne Mackay; Andrew J Rimmer; Richard J Cornall; Matthew A Field; T Daniel Andrews; Christopher C Goodnow; Anselm Enders
Journal:  J Exp Med       Date:  2012-12-24       Impact factor: 14.307

8.  Tracking Differential Gene Expression in MRL/MpJ Versus C57BL/6 Anergic B Cells: Molecular Markers of Autoimmunity.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Biomark Insights       Date:  2008-06-10

9.  The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.

Authors:  Liza Rijvers; Marie-José Melief; Roos M van der Vuurst de Vries; Maeva Stéphant; Jamie van Langelaar; Annet F Wierenga-Wolf; Jeanet M Hogervorst; Anneke J Geurts-Moespot; Fred C G J Sweep; Rogier Q Hintzen; Marvin M van Luijn
Journal:  Eur J Immunol       Date:  2018-09-25       Impact factor: 5.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.